Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention
Read More Pharma Industry News Regor Therapeutics raises $90m for CARD platform in Series B funding round Regor Therapeutics has raised $90 million in a Series B financing round towards the discovery and development of discovery of… bySrinathFebruary 23, 2021
